세계의 암 치료 시장 보고서(2025년)

Cancer Therapy Global Market Report 2025

US $ 4,490 ￦ 6,292,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,095,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,897,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

암 치료 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년에는 연간 평균 성장률(CAGR) 10.2%로 성장할 전망이며, 3,108억 5,000만 달러로 성장이 예측됩니다. 예측 기간 동안 전망되는 성장은 개별화 암 치료에 대한 수요 증가, 외래 암 치료에 대한 주력 강화, 면역요법 채택률 상승, 신흥국의 헬스케어 접근성 개선, 생활습관병 관련 암의 이환율 증가로 초래됩니다. 이 기간 주요 동향에는 암 진단의 기술적 발전, 표적 약물 전달 혁신, 생물제제 연구개발 투자 증가, AI 기반 치료계획 개발, 저침습 암 수술 혁신 등이 있습니다.

암 유병률 상승은 암 치료 시장의 향후 성장을 가속할 것으로 예측됩니다. 암은 체내 이상 세포의 제어 불가능한 증식과 확산을 특징으로 하는 질환군입니다. 암 환자의 증가는 주로 공해나 담배 연기 등의 환경 발암성 물질에 노출될 기회가 늘어난 것에 기인하고 있습니다. 암 치료는 기존의 사례를 치료하고 생존율을 높이며 질병의 진행을 지연시킴으로써 이 유병률 상승을 관리하기 위해 필수적입니다. 예를 들어 2024년 2월 스위스에 본부를 둔 정부 간 기관인 세계보건기구(WHO)는 세계 암 이환수가 2050년까지 새로 3,500만 명을 넘어 2022년 보고된 추정 2,000만 명에서 77% 증가할 것으로 예측했습니다. 이처럼 암 이환율 증가가 암 치료 시장의 확대에 박차를 가하고 있습니다.

암 치료 시장의 주요 기업은 암세포를 식별하고 파괴하기 위해 신체의 면역 시스템을 활용하여 치료 효과를 높이는 면역 종양약 등의 혁신적 치료법의 개발에 주력하고 있습니다. 면역 온콜로지 치료는 암세포를 보다 효과적으로 표적으로 삼아 공격하는 면역계의 능력을 자극 및 증강하는 암 치료의 클래스별입니다. 예를 들면, 2024년 12월, 인도에 거점을 둔 제약회사 Dr. Reddy's Laboratories Ltd.는 인도에서 상인두암 치료로 승인된 최초이자 유일한 면역종양약인 트리팔리맙을 출시했습니다. 이 채용은 이 희귀하고 침공성이 높은 암환자에게 새로운 표적치료 선택지를 제공하는 것으로 면역계의 선진적 활성화로 예후를 개선할 가능성이 있습니다. 인도의 Toripalimab 출시는 충분한 치료를 받지 못한 지역의 선진적인 암 치료 접근성을 향상시키겠다는 Reddy 박사의 헌신적인 노력을 강조하는 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

• 세계의 암 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
• 최종 이용 산업의 분석
• 세계의 암 치료 시장 : 성장률 분석
• 세계의 암 치료 시장 실적 : 규모 및 성장(2019-2024년)
• 세계의 암 치료 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
• 세계의 암 치료 : 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 암 치료 시장 : 치료 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 화학요법
• 표적요법
• 면역요법
• 방사선요법
• 기타 치료 유형
• 세계의 암 치료 시장 : 암 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 혈액암
• 유방암
• 전립선 암
• 소화기 암
• 부인과 암
• 호흡기 암 또는 폐암
• 기타 암 유형
• 세계의 암 치료 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 병원
• 전문 클리닉
• 암 및 방사선 치료 센터
• 세계의 암 치료 시장 : 화학 요법별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 알킬화제
• 대사 길항제
• 항종양 항생제
• 토포이소머라제 억제제
• 유사분열 억제제
• 코르티코스테로이드
• 기타 화학요법제
• 세계의 암 치료 시장 : 표적 요법별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 단일클론항체
• 티로신 키나아제 억제제(TKI)
• mTOR 억제제
• 프로테아좀 억제제
• PARP 억제제
• 기타 타겟 에이전트
• 세계의 암 치료 시장 : 면역 요법별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 면역관문 억제제
• CAR-T 세포 요법
• 암 백신
• 사이토카인
• 종양 용해성 바이러스 요법
• 기타 면역요법
• 세계의 암 치료 시장 : 방사선 치료별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 외부 방사선 치료(EBRT)
• 내부 방사선 요법(밀폐 소선원 요법)
• 전신 방사선 요법
• 정위 방사선 수술(SRS)
• 강도조절 방사선 치료(IMRT)
• 영상 유도 방사선 치료(IGRT)
• 세계의 암 치료 시장 : 기타 치료법별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 호르몬 요법
• 줄기세포 이식
• 광선역학 요법
• 동결요법
• 온열요법

제7장 지역별 및 국가별 분석

• 세계의 암 치료 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 암 치료 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

• 암 치료 시장 : 경쟁 구도
• 암 치료 시장 : 기업 프로파일
  • Pfizer Inc.
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd
  • Merck & Co. Inc.
  • Bayer AG

제31장 기타 주요 기업 및 혁신 기업

• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Novartis International AG
• GlaxoSmithKline PLC
• Elekta AB
• Exelixis Inc.
• Accuray Incorporated
• Akeso Inc.
• NanobIoTix SA
• SOTIO BIoTech as
• AdvanCell Isotopes Pty Ltd
• Axcynsis Therapeutics Pte Ltd
• Clarity Pharmaceuticals Ltd
• Affimed NV
• Aptadel Therapeutics SL

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

• 암 치료 시장(2029년) : 새로운 기회를 제공하는 국가
• 암 치료 시장(2029년) : 새로운 기회를 제공하는 부문
• 암 치료 시장(2029년) : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제36장 부록

AJY

영문 목차

영문목차

Cancer therapy refers to treatments aimed at eliminating or controlling cancer cells within the body. It encompasses several methods, including surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. The selection of treatment depends on the cancer's type, stage, location, and the patient's overall health.

The primary types of cancer therapy include chemotherapy, targeted therapy, immunotherapy, radiotherapy, and others. Chemotherapy involves using potent drugs to kill or inhibit the growth of rapidly dividing cancer cells. It is applied to various cancers such as blood cancer, breast cancer, prostate cancer, gastrointestinal cancer, gynecologic cancer, respiratory or lung cancer, and more. This treatment is utilized by various end users, including hospitals, specialty clinics, and cancer and radiation therapy centers.

The cancer therapy market research report is one of a series of new reports from The Business Research Company that provides cancer therapy market statistics, including the cancer therapy industry global market size, regional shares, competitors with the cancer therapy market share, detailed cancer therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the cancer therapy industry. This cancer therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cancer therapy market size has grown rapidly in recent years. It will grow from $190.44 billion in 2024 to $210.44 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth during the historic period can be attributed to the rising global prevalence of cancer, increasing adoption of chemotherapy treatments, heightened awareness of early cancer diagnosis, greater availability of oncology specialists, and expanded access to hospital-based treatment services.

The cancer therapy market size is expected to see rapid growth in the next few years. It will grow to $310.85 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth projected for the forecast period is driven by increasing demand for personalized cancer therapies, a stronger focus on outpatient cancer care, rising adoption of immunotherapy, improved healthcare access in emerging economies, and a growing incidence of lifestyle-related cancers. Key trends during this period include technological advancements in cancer diagnostics, innovations in targeted drug delivery, increased investment in biologics research and development, the development of AI-based treatment planning, and innovations in minimally invasive cancer surgeries.

The rising prevalence of cancer is expected to drive growth in the cancer therapy market moving forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. The increase in cancer cases is mainly due to greater exposure to environmental carcinogens such as pollution and tobacco smoke. Cancer therapy is vital in managing this rising prevalence by treating existing cases, enhancing survival rates, and slowing disease progression. For example, in February 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, projected that global cancer incidence will exceed 35 million new cases by 2050, marking a 77% rise from the estimated 20 million cases reported in 2022. Thus, the growing prevalence of cancer is fueling the expansion of the cancer therapy market.

Leading companies in the cancer therapy market are concentrating on developing innovative treatments, such as immuno-oncology drugs, which enhance treatment effectiveness by leveraging the body's immune system to identify and destroy cancer cells. Immuno-oncology drugs represent a class of cancer therapies that stimulate or boost the immune system's ability to more effectively target and attack cancer cells. For example, in December 2024, Dr. Reddy's Laboratories Ltd., an India-based pharmaceutical firm, launched Toripalimab, the first and only immuno-oncology drug approved for treating nasopharyngeal cancer in India. This introduction offers a new, targeted treatment option for patients with this rare and aggressive cancer, potentially improving outcomes through advanced immune system activation. The availability of Toripalimab in India highlights Dr. Reddy's dedication to increasing access to advanced cancer therapies in underserved regions.

In December 2023, Pfizer Inc., a pharmaceutical company based in the US, acquired Seagen Inc. for $43 billion. Through this acquisition, Pfizer seeks to enhance its oncology portfolio by incorporating Seagen's advanced antibody-drug conjugate (ADC) technology to deliver more targeted cancer treatments. Seagen Inc., also based in the US, specializes in developing ADCs that accurately target cancer cells while reducing damage to healthy tissue.

Major players in the cancer therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Elekta AB, Exelixis Inc., Accuray Incorporated, Akeso Inc., Nanobiotix S.A., SOTIO Biotech a.s., AdvanCell Isotopes Pty Ltd, Axcynsis Therapeutics Pte Ltd, Clarity Pharmaceuticals Ltd, Affimed N.V., and Aptadel Therapeutics S.L.

North America was the largest region in the cancer therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cancer therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cancer therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer therapy market includes revenues earned by entities by providing services such as hormone therapy, stem cell transplant, cryoablation, and photodynamic therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cancer Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cancer therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Therapy Type: Chemotherapy; Target Therapy; Immunotherapy; Radiotherapy; Other Therapy Types
• 2) By Cancer Type: Blood Cancer; Breast Cancer; Prostate Cancer; Gastrointestinal Cancer; Gynaecologic Cancer; Respiratory Or Lung Cancer; Other Cancer Types
• 3) By End User: Hospitals; Specialty Clinics; Cancer And Radiation Therapy Centers
• Subsegment:
• 1) By Chemotherapy: Alkylating Agents; Antimetabolites; Anti-Tumor Antibiotics; Topoisomerase Inhibitors; Mitotic Inhibitors; Corticosteroids; Other Chemotherapy Drugs
• 2) By Targeted Therapy: Monoclonal Antibodies; Tyrosine Kinase Inhibitors (TKIs); mTOR Inhibitors; Proteasome Inhibitors; PARP Inhibitors; Other Targeted Agents
• 3) By Immunotherapy: Immune Checkpoint Inhibitors; CAR T-cell Therapy; Cancer Vaccines; Cytokines; Oncolytic Virus Therapy; Other Immunotherapies
• 4) By Radiotherapy: External Beam Radiation Therapy (EBRT); Internal Radiation Therapy (Brachytherapy); Systemic Radiation Therapy; Stereotactic Radiosurgery (SRS); Intensity-Modulated Radiation Therapy (IMRT); Image-Guided Radiation Therapy (IGRT)
• 5) By Other Therapy Types: Hormone Therapy; Stem Cell Transplant; Photodynamic Therapy; Cryoablation; Hyperthermia Therapy
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd; Merck & Co. Inc.; Bayer Aktiengesellschaft
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cancer Therapy Market Characteristics

3. Cancer Therapy Market Trends And Strategies

4. Cancer Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cancer Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cancer Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cancer Therapy Market Growth Rate Analysis
• 5.4. Global Cancer Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cancer Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cancer Therapy Total Addressable Market (TAM)

6. Cancer Therapy Market Segmentation

• 6.1. Global Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Target Therapy
• Immunotherapy
• Radiotherapy
• Other Therapy Types
• 6.2. Global Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Cancer
• Breast Cancer
• Prostate Cancer
• Gastrointestinal Cancer
• Gynaecologic Cancer
• Respiratory Or Lung Cancer
• Other Cancer Types
• 6.3. Global Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Cancer And Radiation Therapy Centers
• 6.4. Global Cancer Therapy Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alkylating Agents
• Antimetabolites
• Anti-Tumor Antibiotics
• Topoisomerase Inhibitors
• Mitotic Inhibitors
• Corticosteroids
• Other Chemotherapy Drugs
• 6.5. Global Cancer Therapy Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Tyrosine Kinase Inhibitors (TKIs)
• mTOR Inhibitors
• Proteasome Inhibitors
• PARP Inhibitors
• Other Targeted Agents
• 6.6. Global Cancer Therapy Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immune Checkpoint Inhibitors
• CAR T-cell Therapy
• Cancer Vaccines
• Cytokines
• Oncolytic Virus Therapy
• Other Immunotherapies
• 6.7. Global Cancer Therapy Market, Sub-Segmentation Of Radiotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• External Beam Radiation Therapy (EBRT)
• Internal Radiation Therapy (Brachytherapy)
• Systemic Radiation Therapy
• Stereotactic Radiosurgery (SRS)
• Intensity-Modulated Radiation Therapy (IMRT)
• Image-Guided Radiation Therapy (IGRT)
• 6.8. Global Cancer Therapy Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormone Therapy
• Stem Cell Transplant
• Photodynamic Therapy
• Cryoablation
• Hyperthermia Therapy

7. Cancer Therapy Market Regional And Country Analysis

• 7.1. Global Cancer Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cancer Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cancer Therapy Market

• 8.1. Asia-Pacific Cancer Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cancer Therapy Market

• 9.1. China Cancer Therapy Market Overview
• 9.2. China Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cancer Therapy Market

• 10.1. India Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cancer Therapy Market

• 11.1. Japan Cancer Therapy Market Overview
• 11.2. Japan Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cancer Therapy Market

• 12.1. Australia Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cancer Therapy Market

• 13.1. Indonesia Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cancer Therapy Market

• 14.1. South Korea Cancer Therapy Market Overview
• 14.2. South Korea Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cancer Therapy Market

• 15.1. Western Europe Cancer Therapy Market Overview
• 15.2. Western Europe Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cancer Therapy Market

• 16.1. UK Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cancer Therapy Market

• 17.1. Germany Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cancer Therapy Market

• 18.1. France Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cancer Therapy Market

• 19.1. Italy Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cancer Therapy Market

• 20.1. Spain Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cancer Therapy Market

• 21.1. Eastern Europe Cancer Therapy Market Overview
• 21.2. Eastern Europe Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cancer Therapy Market

• 22.1. Russia Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cancer Therapy Market

• 23.1. North America Cancer Therapy Market Overview
• 23.2. North America Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cancer Therapy Market

• 24.1. USA Cancer Therapy Market Overview
• 24.2. USA Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cancer Therapy Market

• 25.1. Canada Cancer Therapy Market Overview
• 25.2. Canada Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cancer Therapy Market

• 26.1. South America Cancer Therapy Market Overview
• 26.2. South America Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cancer Therapy Market

• 27.1. Brazil Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cancer Therapy Market

• 28.1. Middle East Cancer Therapy Market Overview
• 28.2. Middle East Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cancer Therapy Market

• 29.1. Africa Cancer Therapy Market Overview
• 29.2. Africa Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cancer Therapy Market Competitive Landscape And Company Profiles

• 30.1. Cancer Therapy Market Competitive Landscape
• 30.2. Cancer Therapy Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Cancer Therapy Market Other Major And Innovative Companies

• 31.1. Bristol-Myers Squibb Company
• 31.2. AstraZeneca PLC
• 31.3. Novartis International AG
• 31.4. GlaxoSmithKline PLC
• 31.5. Elekta AB
• 31.6. Exelixis Inc.
• 31.7. Accuray Incorporated
• 31.8. Akeso Inc.
• 31.9. Nanobiotix S.A.
• 31.10. SOTIO Biotech a.s.
• 31.11. AdvanCell Isotopes Pty Ltd
• 31.12. Axcynsis Therapeutics Pte Ltd
• 31.13. Clarity Pharmaceuticals Ltd
• 31.14. Affimed N.V.
• 31.15. Aptadel Therapeutics S.L.

32. Global Cancer Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cancer Therapy Market

34. Recent Developments In The Cancer Therapy Market

35. Cancer Therapy Market High Potential Countries, Segments and Strategies

• 35.1 Cancer Therapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cancer Therapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cancer Therapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료